亚辉龙因脑机接口信披不准确遭上交所监管警示

Core Viewpoint - The company Aihuilong has received a regulatory warning from the Shanghai Stock Exchange due to inconsistent disclosures regarding its strategic partnership with Brain Machine Star Chain Technology, particularly concerning the technology paths involved in their collaboration [1][2]. Group 1: Regulatory Warning - Aihuilong was issued a warning letter by the Shanghai Stock Exchange for failing to provide accurate and complete information regarding its partnership with Brain Machine Star Chain, which raised concerns about potential investor misguidance [1]. - The company’s announcement about the partnership led to a significant increase in its stock price by 6.52% and a trading volume surge of 299% compared to the previous day [1]. Group 2: Partnership Details - Aihuilong signed a strategic cooperation framework agreement with Brain Machine Star Chain to collaborate on product development, market promotion, and equity investment, with Brain Machine Star Chain focusing on both non-invasive and invasive technology paths [1][2]. - Aihuilong clarified that Brain Machine Star Chain's current research products are based solely on non-invasive technology and that no invasive technology is being developed at this stage [2]. Group 3: Financial Performance - For the first three quarters of 2025, Aihuilong reported revenue of approximately 1.287 billion yuan, a year-on-year decrease of 7.69%, and a net profit of about 60.42 million yuan, down 72.36% year-on-year [3]. - The company has cash reserves of 465 million yuan [3].